# Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma

> **NCT07189572** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 168 (estimated)

## Conditions studied

- Otitis Media
- Otitis Media With Effusion After Nasopharyngeal Carcinoma
- Radiotherapy Side Effects
- Radiotherapy Side Effect
- Otitis Media With Effusion (OME)

## Interventions

- **DRUG:** Triamcinolone Acetonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07189572
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2027-08
- **Final completion:** 2027-10
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2025-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07189572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07189572, "Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07189572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
